FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation
Publication information:
Hu J, Liu X, Xia, Zhang Z, Zhang Y, Zhao, Ruan, Luo, Lou, Bai, Wang, Hollingsworth L, Magupalli V, Zhao L, Luo H, Kim, Lieberman, Wu. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation.
Nature Immunology. 2020;21(7):736–745.